Top Markets
Coin of the day
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited

SUNPHARMA
Kedudukan dalam Saham #478
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company,... Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology and ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances; generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.
Harga Saham
$19.63
Modal Pasaran
$47.10B
Perubahan (1 hari)
1.80%
Perubahan (1 tahun)
-7.33%
Negara
IN
Perdagangan Sun Pharmaceutical Industries Limited (SUNPHARMA)

Kategori

Hasil untuk Sun Pharmaceutical Industries Limited (SUNPHARMA)
Hasil pada Dec 2025 TTM: $6.31B
Menurut laporan kewangan terkini daripada Sun Pharmaceutical Industries Limited, hasil semasa syarikat (TTM) ialah $6.31B. Pada tahun 2024, syarikat memperoleh hasil sebanyak $5.82B peningkatan berbanding hasil pada tahun 2023 iaitu $5.34B. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Sun Pharmaceutical Industries Limited dari 2004 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
2026 (TTM) $6.31B 2.69%
2025 $6.15B 5.70%
2024 $5.82B 8.91%
2023 $5.34B 4.87%
2022 $5.09B 11.28%
2021 $4.58B 4.98%
2020 $4.36B 4.14%
2019 $4.19B 3.17%
2018 $4.06B -15.97%
2017 $4.83B 13.79%
2016 $4.24B -3.35%
2015 $4.39B 63.63%
2014 $2.68B 29.00%
2013 $2.08B 31.80%
2012 $1.58B 22.91%
2011 $1.28B 47.70%
2010 $869.23M 3.29%
2009 $841.54M 0.33%
2008 $838.79M 70.54%
2007 $491.84M 33.83%
2006 $367.50M 33.92%
2005 $274.42M 20.98%
2004 $226.82M 0.00%
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
$4.43B -29.76%
FR
$24.76B 292.14%
DE
$28.60B 352.97%
JP
$9.47B 49.96%
US
$25.92B 310.58%
GB